Just 2 Pfizer shots will deplete Omicron hospitalisation rate by 70%, according to a study conducted by Discovery Health Ltd, a leading South African medical-insurance provider that covers 3.7 million clients.
Discover our latest podcast
As more people become infected with the Omicron variant, doctors and scientists are attempting to determine the extent of the strain's potential damage.
Pfizer shot is effective
In the Discovery survey, about 78,000 positive COVID test results from November 15 to December 7 of Omicron infections in South Africa are included. According to the study, Pfizer shots will ensure low hospitalisation rate.
Discovery Health Chief Executive Officer Ryan Noach said:
Pfizer is 33% effective against infection by the Omicron variant
According to the latest study released by Pfizer on Tuesday, Pfizer's experimental COVID pill also proved very effective in keeping patients out of the hospital.
Despite the fact that the probability of children testing positive is substantially lower than that of adults, children under the age of 18 are more likely to end up in the hospital than during prior waves.
Noach added:
The majority of children present with mild disease, with symptoms such as a sore throat, nasal congestion, headache and fever that resolves within three days.
Doesn’t stop mild symptoms
We must remember that the two shot Pfizer will deplete the chances of you being admitted to the hospital, but cannot curb the risk of breakthrough infections.
Which means that, given what we know about how the vaccine functions, we shouldn't be shocked if they're more successful at keeping individuals from becoming unwell than at preventing them from transmitting the virus.
Noach said:
We don’t know how omicron is going to evolve in countries with low vaccination or prior infection rates.
